Similar results were observed in another two tested models, one model involving MET-amplified MKN45 cancer cells with stable SYK knockdown and one model involving EGFR-mutant PC9 cells with stable SYK knockdown (Fig. 1i and Supplementary Fig. S3d). This evidence concerns the gene MET and cancer.